Pages that link to "Q41312128"

The following pages link to Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression (Q41312128):

Displaying 25 items.

• Retroviral integrations in gene therapy trials (Q26991660) (← links)
• A novel intranuclear RNA vector system for long-term stem cell modification (Q28603323) (← links)
• Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand? (Q30364488) (← links)
• An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference (Q33850615) (← links)
• Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence. (Q34249667) (← links)
• A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin (Q34428085) (← links)
• Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease (Q34449867) (← links)
• Gene therapy of chronic granulomatous disease: the engraftment dilemma (Q34473374) (← links)
• Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII (Q34550081) (← links)
• Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector (Q34692989) (← links)
• Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning (Q35285661) (← links)
• Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector. (Q35988663) (← links)
• Prospectives for gene therapy of retinal degenerations (Q36108106) (← links)
• Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In Vivo (Q36369034) (← links)
• Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB. (Q36595683) (← links)
• Transduction of fetal mice with a feline lentiviral vector induces liver tumors which exhibit an E2F activation signature. (Q37690482) (← links)
• Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency (Q37718170) (← links)
• HIV-derived vectors for therapy and vaccination against HIV. (Q37985328) (← links)
• Current progress on gene therapy for primary immunodeficiencies (Q38110363) (← links)
• Immune modulation by genetic modification of dendritic cells with lentiviral vectors. (Q38111096) (← links)
• Lentiviral vectors for cancer immunotherapy and clinical applications (Q38147100) (← links)
• Assessing the risk of T-cell malignancies in mouse models of SCID-X1. (Q41311394) (← links)
• Promoter Competition for Gene Therapy of SCID-X1 (Q45868375) (← links)
• Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia (Q57493528) (← links)
• Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy (Q59349038) (← links)